Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 4 2Phase 2 2Phase 3 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Radiotherapy 17Specimen Handling 16Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11fludarabine 9Fluorodeoxyglucose F18 9X-Rays 8Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Pafolacianine × 1 year × Clear all
NCT06511037 2026-02-27

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

University of California, Irvine

Phase EARLY_PHASE1 Recruiting
10 enrolled
GastrointestinalGynecologic

Gastrointestinal Neoplasms, Peritoneal Neoplasms

NCT07278986 2025-12-12

CYTALUX ISS

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡